Lisboa, R. O., Sekula, R. F., Bezamat, M., Deeley, K., Santana-da-Silva, L. C., & Vieira, A. R. (2022). Pain perception genes, asthma, and oral health: A reverse genetics study. PLOS ONE, 17(11), e0277036. https://doi.org/10.1371/journal.pone.0277036

Cheng, F., Zheng, W., Barbuti, P. A., Bonsi, P., Liu, C., Casadei, N., Ponterio, G., Meringolo, M., Admard, J., Dording, C. M., Yu-Taeger, L., Nguyen, H. P., Grundmann-Hauser, K., Ott, T., Houlden, H., Pisani, A., Krüger, R., & Riess, O. (2022). DYT6 mutated THAP1 is a cell type dependent regulator of the SP1 family. Brain, 145(11), 3968–3984. https://doi.org/10.1093/brain/awac001

Cumbe, V. F. J., Greene, C., Fumo, A. M. T., Fumo, H., Mabunda, D., Gouveia, L. C., Oquendo, M. A., Duarte, C. S., Sidat, M., & Mari, J. de J. (2022). Community Health Workers’ Knowledge, Attitudes, and Practices towards Epilepsy in Sofala, Central Mozambique. International Journal of Environmental Research and Public Health, 19(22), 15420. https://doi.org/10.3390/ijerph192215420

Tropea, M. R., Gulisano, W., Vacanti, V., Arancio, O., Puzzo, D., & Palmeri, A. (2022). Nitric oxide/cGMP/CREB pathway and amyloid-beta crosstalk: From physiology to Alzheimer’s disease. Free Radical Biology and Medicine, 193, 657–668. https://doi.org/10.1016/j.freeradbiomed.2022.11.022

Girach, A., Audo, I., Birch, D. G., Huckfeldt, R. M., Lam, B. L., Leroy, B. P., Michaelides, M., Russell, S. R., Sallum, J. M. F., Stingl, K., Tsang, S. H., & Yang, P. (2022). RNA-based therapies in inherited retinal diseases. Therapeutic Advances in Ophthalmology, 14, 251584142211346. https://doi.org/10.1177/25158414221134602

Herzog, S., Tsai, J., Nichter, B., Kachadourian, L., Harpaz-Rotem, I., & Pietrzak, R. H. (2021). Longitudinal courses of suicidal ideation in U.S. military veterans: a 7-year population-based, prospective cohort study. Psychological Medicine, 52(15), 3570–3579. https://doi.org/10.1017/s0033291721000301

Teng, S., Zhen, F., McRae, B. R., Zhu, E., Frankel, W. N., & Peng, Y. (2022). Sensory regulation of absence seizures in a mouse model of Gnb1 encephalopathy. IScience, 25(11), 105488. https://doi.org/10.1016/j.isci.2022.105488

McGuirt, A., Pigulevskiy, I., & Sulzer, D. (2022). Developmental regulation of thalamus-driven pauses in striatal cholinergic interneurons. IScience, 25(11), 105332. https://doi.org/10.1016/j.isci.2022.105332

Scotti, A., Sturla, M., Granada, J. F., Kodali, S. K., Coisne, A., Mangieri, A., Godino, C., Ho, E., Goldberg, Y., Chau, M., Jorde, U. P., Garcia, M. J., Maisano, F., Bapat, V. N., Ailawadi, G., & Latib, A. (2022). Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies. EuroIntervention, 18(10), 840–851. https://doi.org/10.4244/eij-d-22-00442

Laleu, B., Rubiano, K., Yeo, T., Hallyburton, I., Anderson, M., Crespo‐Fernandez, B., Gamo, F., Antonova‐Koch, Y., Orjuela‐Sanchez, P., Wittlin, S., Jana, G. P., Maity, B. C., Chenu, E., Duffy, J., Sjö, P., Waterson, D., Winzeler, E., Guantai, E., Fidock, D. A., & Hansson, T. G. (2022). Exploring a Tetrahydroquinoline Antimalarial Hit from the Medicines for Malaria Pathogen Box and Identification of its Mode of Resistance as PfeEF2. ChemMedChem, 17(22). Portico. https://doi.org/10.1002/cmdc.202200393

Zeidan, A. M., Platzbecker, U., Garcia-Manero, G., Sekeres, M. A., Fenaux, P., DeZern, A. E., Greenberg, P. L., Savona, M. R., Jurcic, J. G., Verma, A. K., Mufti, G. J., Buckstein, R., Santini, V., Shetty, J. K., Ito, R., Zhang, J., Zhang, G., Ha, X., Backstrom, J. T., & Komrokji, R. S. (2022). Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts. Blood, 140(20), 2170–2174. https://doi.org/10.1182/blood.2022016171

Lucchini, M., Zuraikat, F. M., & St-Onge, M.-P. (2022). Interrelationships Between Sleep, Obesity, and Glycemic Control in Children. Journal of the Endocrine Society, 7(1). https://doi.org/10.1210/jendso/bvac164

Deckler, E., Ferland, M., Brazis, S., Mayer, M. R., Carlson, M., & Kantrowitz, J. T. (2022). Challenges and Strategies for the Recruitment of Patients With Schizophrenia in a Research Setting. International Journal of Neuropsychopharmacology, 25(11), 924–932. https://doi.org/10.1093/ijnp/pyac058

Brucato, G., Appelbaum, P. S., Hesson, H., Shea, E. A., Dishy, G., Lee, K., Pia, T., Syed, F., Villalobos, A., Wall, M. M., Lieberman, J. A., & Girgis, R. R. (2021). Psychotic symptoms in mass shootings v. mass murders not involving firearms: findings from the Columbia mass murder database. Psychological Medicine, 52(15), 3422–3430. https://doi.org/10.1017/s0033291721000076

Ahmed Ali, U., & Kiran, R. P. (2022). Surgery for Crohn’s disease: upfront or last resort? Gastroenterology Report, 10. https://doi.org/10.1093/gastro/goac063

Sokol, Y., Levin, C., Linzer, M., Rosensweig, C., Hubner, S., Gromatsky, M., Walsh, S., Dixon, L., & Goodman, M. (2022). Theoretical model of recovery following a suicidal episode (COURAGE): scoping review and narrative synthesis. BJPsych Open, 8(6). https://doi.org/10.1192/bjo.2022.599

Pan, Y., Wang, D., Chaudhary, M. F. A., Shao, W., Gerard, S. E., Durumeric, O. C., Bhatt, S. P., Barr, R. G., Hoffman, E. A., Reinhardt, J. M., & Christensen, G. E. (2022). Robust Measures of Image-Registration-Derived Lung Biomechanics in SPIROMICS. Journal of Imaging, 8(11), 309. https://doi.org/10.3390/jimaging8110309

Iturria-Medina, Y., Adewale, Q., Khan, A. F., Ducharme, S., Rosa-Neto, P., O’Donnell, K., Petyuk, V. A., Gauthier, S., De Jager, P. L., Breitner, J., & Bennett, D. A. (2022). Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer’s disease progression and heterogeneity. Science Advances, 8(46). https://doi.org/10.1126/sciadv.abo6764

Deng, F., Phillips, M. R., Cai, B., Yu, G., Qian, M., Grivel, M. M. R., Chen, H., Ouyang, X., Xue, F., Zhao, M., Kegeles, L. S., Susser, E. S., Keshavan, M. S., Stone, W. S., & Yang, L. H. (2021). Comparison of social cognition using an adapted Chinese version of the Reading the Mind in the Eyes Test in drug-naive and regularly medicated individuals with chronic schizophrenia and healthy controls in rural China. Psychological Medicine, 52(15), 3655–3667. https://doi.org/10.1017/s003329172100043x

Hay, J. A., Kissler, S. M., Fauver, J. R., Mack, C., Tai, C. G., Samant, R. M., Connolly, S., Anderson, D. J., Khullar, G., MacKay, M., Patel, M., Kelly, S., Manhertz, A., Eiter, I., Salgado, D., Baker, T., Howard, B., Dudley, J. T., Mason, C. E., … Grad, Y. H. (2022). Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: A retrospective cohort study. ELife, 11. CLOCKSS. https://doi.org/10.7554/elife.81849

Sevitz, J. S., Borders, J. C., Dakin, A. E., Kiefer, B. R., Alcalay, R. N., Kuo, S.-H., & Troche, M. S. (2022). Rehabilitation of Airway Protection in Individuals With Movement Disorders: A Telehealth Feasibility Study. American Journal of Speech-Language Pathology, 31(6), 2741–2758. https://doi.org/10.1044/2022_ajslp-22-00063

Melody, M., St. Pierre, F., Helenowski, I., Pearse, W. B., Vakkalagadda, C. V., Leventhal, J. R., Friedewald, J., Ho, B., Ganger, D., Winter, J. N., Gordon, L. I., Lin, A. Y., Karmali, R., Ma, S., Pro, B., & Moreira, J. (2022). Impact of Extranodal Disease Involvement on Outcomes in Post-Transplant Lymphoproliferative Disorder. Blood, 140(Supplement 1), 6674–6675. https://doi.org/10.1182/blood-2022-164724

Qiu, A., Wang, L., Dei Zotti, F., Hudson, K. E., Hod, E. A., & La Carpia, F. (2022). Iron Overload and Iron-Induced Microbiome Changes May Affect Lymphoid Levels Post Bone Marrow Transplant and Graft-Versus-Host Disease Survival in Mice. Blood, 140(Supplement 1), 2465–2466. https://doi.org/10.1182/blood-2022-167300

Di Meo, F., Iyer, A., Akama, K., Yu, C., Cheng, R., Cesarano, A., Marino, S., Aljoufi, A., Soni, R., Roda, J. M., Sissons, J., Vu, L. P., Guzman, M. L., Huang, K., Roodman, D. G., & Perna, F. (2022). A Novel Bi-Specific T-Cell Engager Targeting ILT3 Is Potently Effective in Multiple Myeloma. Blood, 140(Supplement 1), 671–672. https://doi.org/10.1182/blood-2022-167584

Stiefel, J., Flower, A. M., Botwinick, M., Ford, M., Foti, A., Gandhi, M., Slovin, J., Smilow, E., Bowers, A., Karpel, H., Schwartz, L. Y., Fraint, E., Gennarini, L. M., Gardner, S. L., Raetz, E. A., Shah, N. C., Chen, J., Krajewski, J., Hijiya, N., … Sulis, M. L. (2022). Antigen Directed Therapy Pre-Transplant Confers Superior Post-Transplant Survival Outcome Compared to Conventional Chemotherapy in Pediatric Patients with Relapsed and Refractory B-ALL. Blood, 140(Supplement 1), 7763–7765. https://doi.org/10.1182/blood-2022-160272

Ford, M., Orlando, E., Jin, Z., Lipsky, A. H., Sawas, A., Pro, B., & Amengual, J. E. (2022). Prevalence and Characterization of EBV-Negative Post-Transplant Lymphoproliferative Disorder. Blood, 140(Supplement 1), 3777–3778. https://doi.org/10.1182/blood-2022-160147

Melody, M., St. Pierre, F., Helenowski, I., Pearse, W. B., Vakkalagadda, C., Leventhal, J. R., Ho, B., Friedewald, J., Ganger, D., Winter, J. N., Gordon, L. I., Lin, A. Y., Karmali, R., Ma, S., Pro, B., & Moreira, J. (2022). Posttransplant Lymphoproliferative Disorder (PTLD) Following Transplantation at Northwestern University: Choice of Immunosuppressive Agents Does Not Impact Outcomes in PTLD. Blood, 140(Supplement 1), 3833–3834. https://doi.org/10.1182/blood-2022-167812

Balamurugan, M. A., Desiraju, S., Wojczyk, B. S., Namachivayam, K., Chung, Y., Guzman, P., & Krishnan, M. (2022). RBC Transfusion to Severe Anemic Murine Neonates Leads to Systemic Inflammation. Blood, 140(Supplement 1), 5702–5703. https://doi.org/10.1182/blood-2022-159574

Chapman-Fredricks, J. R., Thakkar, D., Alderuccio, J. P., Naresh, K. N., Ondrejka, S. L., Hsi, E. D., Xu, M. L., Paulson, N., Koff, J. L., Jaye, D. L., Cohen, J. B., Ortved Gang, A., Leeman-Neill, R. J., Dave, T., Happ, L., Love, C., Zandi, S., Naushad, H., Mason, E. F., … Lossos, I. S. (2022). Extranodal Marginal Zone Lymphomas Show Recurrent Mutations in DNA Repair Genes, Cancer-Associated Proliferative Signaling and NOTCH1 Signaling Pathways, Regardless of Anatomic Site. Blood, 140(Supplement 1), 6378–6380. https://doi.org/10.1182/blood-2022-165616

Estrella, B., Pazos, M. A., Ricker, E. C., Ryu, Y. K., Piorczynski, T. B., Liu, Y., Tolu, S., & Amengual, J. E. (2022). First-in-Class Histone Acetyltransferase (HAT) Activator, YF2, Modulates Immune Evasion in DLBCL, Enhancing the Effects of Immune Checkpoint Blockade. Blood, 140(Supplement 1), 358–359. https://doi.org/10.1182/blood-2022-166929

Ford, M., Orlando, E., Jin, Z., Lipsky, A. H., Sawas, A., Pro, B., & Amengual, J. E. (2022). Treatment Modalities Effect on Outcome in Post-Transplant Lymphoproliferative Disorder. Blood, 140(Supplement 1), 3794–3795. https://doi.org/10.1182/blood-2022-163813

Yu, L., Hsieh, Y.-C., Pearse, R. V., Wang, Y., Petyuk, V. A., Schneider, J. A., Buchman, A. S., Seyfried, N. T., De Jager, P. L., Young-Pearse, T. L., & Bennett, D. A. (2022). Association of AK4 Protein From Stem Cell–Derived Neurons With Cognitive Reserve. Neurology, 99(20). https://doi.org/10.1212/wnl.0000000000201120

Angelopoulou, E., Bozi, M., Simitsi, A.-M., Koros, C., Antonelou, R., Papagiannakis, N., Maniati, M., Poula, D., Stamelou, M., Vassilatis, D. K., Michalopoulos, I., Geronikolou, S., Scarmeas, N., & Stefanis, L. (2022). Clinical differences between early-onset and mid-and-late-onset Parkinson’s disease: Data analysis of the Hellenic Biobank of Parkinson’s disease. Journal of the Neurological Sciences, 442, 120405. https://doi.org/10.1016/j.jns.2022.120405

Breyer, L. M., Wang, H., Gu, D., Johnstone, B. H., Ma, H., Woods, E. J., & Mapara, M. Y. (2022). Transplantation of Hematopoietic Stem and Progenitor Cells from Cadaveric Organ Donors Leads to Long-Term Multilineage Engraftment in NSG Mice. Blood, 140(Supplement 1), 7347–7348. https://doi.org/10.1182/blood-2022-169787

Schroers-Martin, J., Garofalo, A., Soo, J., Boegeholz, J., Alig, S. K., Sworder, B., Liu, C. L., Luikart, H., Gamino, G., Morales, D., Freystätter, K., Hamilton, J., Kurtz, D. M., Hollander, S., Rosenthal, D., Dhillon, G., Raikhelkar, J., Verleden, S., Nijland, M., … Alizadeh, A. A. (2022). Tumor Microenvironment Determinants of Immunotherapy Response Identified By Integrated Host & Viral Analysis of Post-Transplant Lymphoproliferative Disorders. Blood, 140(Supplement 1), 172–174. https://doi.org/10.1182/blood-2022-158647

Fu, J., Li, S., Ma, H., Yang, J., Brown, L. M., Pagnotti, G. M., Weiss, S. J., Mapara, M. Y., & Lentzsch, S. (2022). The Novel Role of Checkpoint Inhibitor PD-1H/VISTA in Osteoclast Cytoskeleton Regulation and Multiple Myeloma Bone Disease. Blood, 140(Supplement 1), 9930–9932. https://doi.org/10.1182/blood-2022-169921

Lim, E. A., Bendell, J. C., Falchook, G. S., Bauer, T. M., Drake, C. G., Choe, J. H., George, D. J., Karlix, J. L., Ulahannan, S., Sachsenmeier, K. F., Russell, D. L., Moorthy, G., Sidders, B. S., Pilling, E. A., Chen, H., Hattersley, M. M., Das, M., Kumar, R., Pouliot, G. P., & Patel, M. R. (2022). Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors. Clinical Cancer Research, 28(22), 4871–4884. https://doi.org/10.1158/1078-0432.ccr-22-0612

Roy, I., Epperla, N., Shouse, G., Romancik, J. T., Moyo, T. K., Kenkre, V. P., Ollila, T. A., Fitzgerald, L. A., Hess, B. T., Evens, A. M., Zurko, J., Chowdhury, S. M., Annunzio, K., Ferdman, R., Bhansali, R. S., Harris, E. I., Sorrell, M., Liu, J., Nizamuddin, I. A., … Karmali, R. (2022). Consensus Cachexia Criteria Are Independently Linked to Progression Free and Overall Survival in Multi-Site Analysis of Patients with Aggressive B-Cell Lymphomas Treated with CAR T-Cell Therapy. Blood, 140(Supplement 1), 2416–2418. https://doi.org/10.1182/blood-2022-163822

Blachly, J. S., Stephens, D. M., Ye, J. C., Lamanna, N., Jain, N., Niesman, M., Zhang, K., & Woyach, J. A. (2022). Initial Results from a Phase 1/2 Dose Escalation and Expansion Study Evaluating MS-553, a Novel and Selective PKCβ Inhibitor, in Patients with CLL/SLL. Blood, 140(Supplement 1), 2324–2325. https://doi.org/10.1182/blood-2022-171203

Platzbecker, U., Komrokji, R. S., Fenaux, P., Zeidan, A. M., Sekeres, M. A., Savona, M. R., Madanat, Y. F., Santini, V., Van Eygen, K., Raza, A., Germing, U., Berry, T., Dougherty, S., Shah, S., Sun, L., Huang, F., Feller, F., Wan, Y., Ikin, A., & Sherman, L. (2022). Imetelstat Achieved Prolonged, Continuous Transfusion Independence (TI) in Patients with Heavily Transfused Non-Del(5q) Lower-Risk Myelodysplastic Syndrome (LR-MDS) Relapsed/Refractory (R/R) to Erythropoiesis Stimulating Agents (ESAs) within the IMerge Phase 2 Study. Blood, 140(Supplement 1), 1106–1108. https://doi.org/10.1182/blood-2022-169050

McCurdy, A., Seow, H., Pond, G. R., Gayowsky, A., Chakraborty, R., Visram, A., Kaedbey, R., D’Souza, A., Mohyuddin, G. R., Fonseca, R., & Mian, H. S. (2022). Causes of Death Among Patients with Multiple Myeloma: A 10 Year Longitudinal Analysis of a Population-Based Cohort in Ontario, Canada. Blood, 140(Supplement 1), 427–429. https://doi.org/10.1182/blood-2022-157815

Chakraborty, R., Behera, T. R., Li, H., Dean, R. M., Hill, B. T., Jagadeesh, D., Winter, A., Anwer, F., Pohlman, B., Sobecks, R. M., Hamilton, B. K., & Majhail, N. S. (2022). Feasibility of Patient-Reported Outcome Assessment in the Acute Phase after CAR T-Cell Therapy in Lymphoid Malignancies: A Pilot Study. Blood, 140(Supplement 1), 10926–10927. https://doi.org/10.1182/blood-2022-166904

Ross, A. J., Baggott, C., Prabhu, S., Pacenta, H., Philips, C., Rossoff, J., Stefanski, H. E., Talano, J., Moskop, A., Baumeister, S. H. C., Verneris, M. R., Myers, G. D., Karras, N., Qayed, M., Hermiston, M. L., Satwani, P., Krupski, C., Keating, A. K., Wilcox, R., … Skiles, J. L. (2022). Obesity Associates with Inferior Outcomes and Toxicity in Pediatric and Young Adult Patient with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Treated with Commercially Manufactured Tisagenlecleucel. Blood, 140(Supplement 1), 10419–10421. https://doi.org/10.1182/blood-2022-163336

Walters, M. C., Thompson, A. A., Kwiatkowski, J. L., Parikh, S., Mapara, M. Y., Rifkin-Zenenberg, S., Aygun, B., Kasow, K. A., Miller, A., Zhang, L., Chawla, A., Macari, E. R., Pierciey, F. J., Tisdale, J. F., & Kanter, J. (2022). Lovo-cel (bb1111) Gene Therapy for Sickle Cell Disease: Updated Clinical Results and Investigations into Two Cases of Anemia from Group C of the Phase 1/2 HGB-206 Study. Blood, 140(Supplement 1), 26–28. https://doi.org/10.1182/blood-2022-162288

Fabrizio, V. A., Miller, K., Baggott, C., Prabhu, S., Pacenta, H., Phillips, C. L., Rossoff, J., Stefanski, H. E., Talano, J., Moskop, A., Baumeister, S. H. C., Myers, G. D., Karras, N., Brown, P. A., Qayed, M., Hermiston, M. L., Satwani, P., Krupski, C., Wilcox, R., … Schultz, L. M. (2022). Peripheral Blast Count at Apheresis Acts Independent of Disease Burden As a Risk Factor for Survival Following Tisagenlecleucel in Children and Young Adults. Blood, 140(Supplement 1), 4661–4663. https://doi.org/10.1182/blood-2022-169603

Koff, J. L., Kositsky, R., Jaye, D. L., Churnetski, M. C., Baird, K., O’Leary, C. B., Flowers, C. R., Leppa, S., Karjalainen-Lindsberg, M.-L., Li, S., Xu, J., Pedersen, M. Ø., Gang, A. O., Naresh, K. N., Leeman-Neill, R. J., Au Yeung, K. H. R., Qureishi, H. N., Iqbal, J., Chapman-Fredricks, J. R., … Cohen, J. B. (2022). Mutations of ATM Confer a Risk of Inferior Survival in Patients with TP53-wild Type Mantle Cell Lymphoma. Blood, 140(Supplement 1), 3500–3503. https://doi.org/10.1182/blood-2022-168002

Naqvi, S. A. A., Fatima, S., Asghar, N., Ijaz, H., Ayaz, A., He, H., Husnain, M., Chakraborty, R., Riaz, I., & Aljama, M. A. (2022). Post Autologous Stem Cell Transplant Maintenance in Patients with Newly Diagnosed Multiple Myeloma: A Network Meta-Analysis. Blood, 140(Supplement 1), 10111–10113. https://doi.org/10.1182/blood-2022-170869

Mato, A. R., Woyach, J. A., Brown, J. R., Ghia, P., Patel, K., Eyre, T. A., Munir, T., Lech-Marańda, E., Lamanna, N., Tam, C. S., Seymour, J. F., Shah, N. N., Coombs, C. C., Ujjani, C. S., Patel, M. R., Fakhri, B., Cheah, C. Y., Alencar, A. J., Cohen, J. B., … Jurczak, W. (2022). Efficacy of Pirtobrutinib in Covalent BTK-Inhibitor Pre-Treated Relapsed / Refractory CLL/SLL: Additional Patients and Extended Follow-up from the Phase 1/2 BRUIN Study. Blood, 140(Supplement 1), 2316–2320. https://doi.org/10.1182/blood-2022-159497

Shah, N. N., Wang, M. L., Brown, J. R., Patel, K., Woyach, J. A., Wierda, W. G., Ujjani, C. S., Eyre, T. A., Zinzani, P. L., Alencar, A. J., Gastinne, T., Ghia, P., Lamanna, N., Hoffmann, M., Patel, M. R., Flinn, I. W., Gerson, J. N., Ma, S., Coombs, C. C., … Mato, A. R. (2022). Safety and Tolerability of Pirtobrutinib Monotherapy in Patients with B-Cell Malignancies Who Were Previously Intolerant to a Covalent BTK Inhibitor: Results from the Phase 1/2 BRUIN Study. Blood, 140(Supplement 1), 4127–4132. https://doi.org/10.1182/blood-2022-159035

Usmani, S., Patel, K., Hari, P., Berdeja, J., Alsina, M., Vij, R., Raje, N., Leleu, X., Dhodapkar, M., Reshef, R., Truppel-Hartmann, A., Basudhar, D., Thompson, E., Zheng, X., Ananthakrishnan, R., Greggio, C., Favre-Kontula, L., Sternas, L., & San-Miguel, J. (2022). KarMMa-2 Cohort 2a: Efficacy and Safety of Idecabtagene Vicleucel in Clinical High-Risk Multiple Myeloma Patients with Early Relapse after Frontline Autologous Stem Cell Transplantation. Blood, 140(Supplement 1), 875–877. https://doi.org/10.1182/blood-2022-162469